301089 拓新藥業
按盤價 
37.780 +6.300 (+20.013%)
37.780 +6.300 (+20.013%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.230 | -1.260 | 16.316 | 23.166 | 8.275 |
| 總資產報酬率 ROA (%) | -0.203 | -1.106 | 13.202 | 17.704 | 5.616 |
| 投入資產回報率 ROIC (%) | -0.223 | -1.222 | 15.150 | 20.536 | 6.490 | 邊際利潤分析 |
| 銷售毛利率 (%) | 30.658 | 29.867 | 57.876 | 60.114 | 37.915 |
| 營業利潤率 (%) | -3.850 | -5.624 | 38.502 | 41.963 | 15.771 |
| 息稅前利潤/營業總收入 (%) | -4.234 | -7.388 | 37.483 | 41.080 | 17.231 |
| 淨利潤/營業總收入 (%) | -3.675 | -4.715 | 29.093 | 36.514 | 13.077 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 190.158 | 82.829 | 100.573 | 97.553 | 99.308 |
| 價值變動淨收益/利潤總額(%) | -34.599 | -5.600 | 2.248 | 1.775 | 0.806 |
| 營業外收支淨額/利潤總額(%) | 5.892 | 14.475 | -1.627 | -1.236 | -1.542 | 償債能力分析 |
| 流動比率 (X) | 4.135 | 4.095 | 4.227 | 2.392 | 3.129 |
| 速動比率 (X) | 2.926 | 3.013 | 3.177 | 1.823 | 2.473 |
| 資產負債率 (%) | 11.574 | 11.701 | 12.818 | 25.329 | 21.264 |
| 帶息債務/全部投入資本 (%) | 0.290 | 0.208 | 0.753 | 8.550 | 8.033 |
| 股東權益/帶息債務 (%) | 33,547.546 | 46,823.941 | 12,857.691 | 1,037.226 | 1,102.903 |
| 股東權益/負債合計 (%) | 764.017 | 754.662 | 680.152 | 294.798 | 370.289 |
| 利息保障倍數 (X) | 29.589 | 9.108 | -93.138 | -110.789 | 10.137 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 78.108 | 98.289 | 41.735 | 22.814 | 33.946 |
| 存貨周轉天數 (天) | 250.943 | 233.101 | 227.715 | 234.763 | 188.665 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 16/05/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
